4666 J ournal of Medicinal Chemistry, 2000, Vol. 43, No. 24
Camps et al.
(7) Kozikowsky, A. P.; Campiani, G.; Sun, L. Q.; Wang, S.; Saxena,
A.; Doctor, B. P. Identification of a More Potent Analogue of the
Naturally Ocurring Alkaloid Huperzine A. Predictive Molecular
Modeling of its Interaction with AChE. J . Am. Chem. Soc. 1996,
118, 11357-11362.
(27) Beverung, J r., W. N.; Partyka, A. Optionally Substituted 1,2,3,5-
Tetrahydroimidazo[2,1-b]quinazolin-2-ones and 6H-1,2,3,4-Tet-
rahydropyrimido[2,1-b]quinazolin-2-ones. U.S. Patent 3.932.407,
Bristol-Myers Co., 1976.
(28) Aguado, F.; Badia, A.; Ban˜os, J . E.; Bosch, F.; Bozzo, C.; Camps,
P.; Contreras, J .; Dierssen, M.; Escolano, C.; Go¨rbig, D. M.;
Mun˜oz-Torrero, D.; Pujol, M. D.; Simon, M.; Va´zquez, M. T.;
Vivas, N. M. Synthesis and Evaluation of Tacrine-Related
Compounds for the Treatment of Alzheimer’s Disease. Eur. J .
Med. Chem. 1994, 29, 205-221.
(29) Badia, A.; Ban˜os, J . E.; Camps, P.; Contreras, J .; Go¨rbig, D. M.;
Mun˜oz-Torrero, D.; Simon, M.; Vivas, N. M. Synthesis and
Evaluation of Tacrine-Huperzine A Hybrids as Acetylcholinest-
erase Inhibitors of Potential Interest for the Treatment of
Alzheimer’s Disease. Bioorg. Med. Chem. 1998, 6, 427-440.
(30) Ellman, G. L.; Courtney, K. D.; Andres, B. J r.; Featherstone, R.
M. A New and Rapid Colorimetric Determination of Acetylcho-
linesterase Activity. Biochem. Pharmacol. 1961, 7, 88-95.
(31) Kawakami, H.; Ohuchi, R.; Kitano, M.; Ono, K. Quinoline
Derivatives. Patent EPO 0 268 871 A1, Sumitomo Pharmaceu-
ticals Co. Ltd., 1987.
(32) Benzi, G.; Moretti, A. Is there a Rationale for the Use of
Acetylcholinesterase Inhibitors in the Therapy of Alzheimer’s
Disease? Eur. J . Pharmacol. 1998, 346, 1-13.
(33) Dixon, M.; Webb, E. C. Enzymes, 3rd ed.; Longman: London,
1979.
(34) Since the substrate concentration in the in vitro assays (per-
formed at 298 K) was the same for all the inhibitors, the
experimental differences in binding free energy can be derived
from the competitive inhibition equation IC50 ) Ki(1 + [S]/Km),
where Km and Ki are Michaelis and enzyme-inhibitor dissocia-
tion constants, respectively. The IC50 value of (-)-15 for AChE
inhibition from bovine erythocytes is 47.1 ( 6.3 nM.1
(35) Ban˜os, J . E.; Badia, A.; J ane´, F. Facilitatory Action of Adrenergic
Drugs on Muscle Twich Evoked by Nerve Stimulation in the
Curarized Rat Phrenic-Hemidiaphragm. Arch. Int. Pharmaco-
dyn. 1988, 293, 219-227.
(36) Riesz, M.; Kapati, E.; Szporni, L. Antagonism of Non-Depolar-
izing Neuromuscular Blockade by Aminopyridines in Cats. J .
Pharm. Pharmacol. 1986, 38, 156-158.
(37) Wlodek, S. T.; Antosiewicz, J .; McCammon, J . A.; Straatsma, T.
P.; Gilson, M. K.; Briggs, J . M.; Humblet, C.; Sussman, J . L.
Binding of Tacrine and 6-Chlorotacrine by Acetylcholinesterase.
Biopolymers 1996, 38, 109-117.
(38) Hariharan, P. C.; Pople, J . A. Theoret. Chim. Acta 1973, 28, 213-
219.
(39) Frisch, M. J .; Trucks, G. W.; Schlegel, H. B.; Gill, P. M. W.;
J ohnson, B. G.; Robb, M. A.; Cheeseman, J . R.; Keith, T. A.;
Petersson, G. A.; Montgomery, J . A.; Raghavachari, K.; Al-
Laham, M. A.; Zakrzewski, V. G.; Ortiz, J . V.; Foresman, J . B.;
Cioslowski, J .; Stefanov, B. B.; Nanayakkara, A.; Challacombe,
M.; Peng, C. Y.; Ayala, P. Y.; Chen, W.; Wong, M. W.; Andres,
J . L.; Replogle, E. S.; Gomperts, R.; Martin, R. L.; Fox, D. J .;
Binkley, J . S.; Defrees, D. J .; Baker, J .; Stewart, J . P.; Head-
Gordon, M.; Gonzalez, C.; Pople, J . A. Gaussian 94, revision A.1;
Gaussian Inc.: Pittsburgh, PA, 1995.
(40) J orgensen, W. L.; Chandrasekhar, J .; Madura, J . D.; Impey, R.
W.; Klein, M. L. Comparison of Sample Potential Functions for
Simulating Liquid Water. J . Chem. Phys. 1983, 79, 926-935.
(41) Pearlman, D. A. Determining the Contributions of Constraints
in Free Energy Calculations: Development, Characterization,
and Recommendations. J . Chem. Phys. 1993, 98, 8946-8957.
(42) Cornell, W. D.; Cieplak, P.; Bayly, C. I.; Gould, I. R.; Merz, K.;
Ferguson, D. M.; Spellmeyer, D. C.; Fox, T.; Caldwell, J . W.;
Kollman, P. A. Second Generation Force Field for the Simulation
of Proteins, Nucleic Acids, and Organic Molecules. J . Am. Chem.
Soc. 1995, 117, 5179-5197.
(8) Kozikowsky, A. P.; Tu¨ckmantel, W. Chemistry, Pharmacology,
and Clinical Efficacy of the Chinese Nootropic Agent Huperzine
A. Acc. Chem. Res. 1999, 32, 641-650.
(9) Bai, D. L.; Tang, X. C.; He, X. C. Huperzine A, a Potential
Therapeutic Agent for Treatment of Alzheimer’s Disease. Curr.
Med. Chem. 2000, 7, 355-374.
(10) Pang, Y.-P.; Quiram, P.; J elacic, T.; Hong, F.; Brimijoin, S. Highly
Potent, Selective, and Low Cost Bis-Tetrahydroaminacrine
Inhibitors of Acetylcholinesterase. J . Biol. Chem. 1996, 271,
23646-23649.
(11) Carlier, P. R.; Han, Y. F.; Chow, E. S.-H.; Li, C. P.-L.; Wang,
H.; Lieu, T. X.; Wong, H. S.; Pang, Y.-P. Evaluation of Short-
tether Bis-THA AChE Inhibitors. A Further Test of the Dual
Binding Site Hypothesis. Bioorg. Med. Chem. 1999, 7, 351-357.
(12) Carlier, P. R.; Chow, E. S.-H.; Han, Y.; Liu, J .; El Yazal, J .; Pang,
Y.-P. Heterodimeric Tacrine-Based Acetylcholinesterase Inhibi-
tors: Investigating Ligand-Peripheral Site Interactions. J . Med.
Chem. 1999, 42, 4225-4231.
(13) Carlier, P. R.; Du, D.-M.; Han, Y.; Liu, J .; Pang, Y.-P. Potent,
Easily Synthesized Huperzine A-Tacrine Hybrid Acetylcholin-
esterase Inhibitors. Bioorg. Med. Chem. Lett. 1999, 9, 2335-
2338.
(14) Carlier, P. R.; Du, D.-M.; Han, Y.-F.; Liu, J .; Perola, E.; Williams,
I. D.; Pang, Y.-P. Dimerization of an Inactive Fragment of
Huperzine A Produces a Drug with Twice the Potency of the
Natural Product. Angew. Chem., Int. Ed. Engl. 2000, 39, 1775-
1777.
(15) Mary, A.; Renko, D. Z.; Guillou, C.; Thal, C. Potent Acetylcho-
linesterase Inhibitors: Design, Synthesis, and Structure-Activ-
ity Relationships of Bis-interacting Ligands in the Galanthamine
Series. Bioorg. Med. Chem. 1998, 6, 1835-1850.
(16) Zeng, F.; J iang, H.; Zhai, Y.; Zhang, H.; Chen, K.; J i, R. Synthesis
and Acetylcholinesterase Inhibitory Activity of Huperzine
A-E2020 Combined Compound. Bioorg. Med. Chem. Lett. 1999,
9, 3279-3284.
(17) Camps, P.; El Achab, R.; Go¨rbig, D. M.; Morral, J .; Mun˜oz-
Torrero, D.; Badia, A.; Ban˜os, J . E.; Vivas, N. M.; Barril, X.;
Orozco, M.; Luque, F. J . Synthesis, in Vitro Pharmacology, and
Molecular Modeling of Very Potent Tacrine-Huperzine A Hybrids
as Acetylcholinesterase Inhibitors of Potential Interest for the
Treatment of Alzheimer’s Disease. J . Med. Chem. 1999, 42,
3227-3242.
(18) Barril, X.; Orozco, M.; Luque, F. J . Predicting Relative Free
Energies of Tacrine-Huperzine A Hybrids as Inhibitors of
Acetylcholinesterase. J . Med. Chem. 1999, 42, 5110-5119.
(19) Camps, P.; Contreras, J .; Font-Bardia. M.; Morral, J .; Mun˜oz-
Torrero, D.; Solans, X. Enantioselective Synthesis of Tacrine-
Huperzine A Hybrids. Preparative Chiral MPLC Separation of
Their Racemic Mixtures and Absolute Configuration Assign-
ments by X-ray Diffraction Analysis. Tetrahedron: Asymmetry
1998, 9, 835-849.
(20) Camps, P.; Cusack, B.; Mallender, W. D.; El Achab, R.; Morral,
J .; Mun˜oz-Torrero, D.; Rosenberry, T. L. Huprine X is a Novel
High-Affinity Inhibitor of Acetylcholinesterase That is of Interest
for Treatment of Alzheimer’s Disease. Mol. Pharmacol. 2000,
57, 409-417.
(21) Camps, P.; El Achab, R.; Font-Bardia. M.; Go¨rbig, D. M.; Morral,
J .; Mun˜oz-Torrero, D.; Solans, X.; Simon, M. Easy Synthesis of
7-Alkylbicyclo[3.3.1]non-6-en-3-ones by Silica Gel-Promoted Frag-
mentation of 3-Alkyl-2-oxaadamant-1-yl Mesylates. Tetrahedron
1996, 52, 5867-5880.
(22) Sepiol, J .; Mirek, J .; Soulen, R. L. Cyclization of Ylidene-
Halodinitriles and Ylidenecyanoacetates Obtained from Mesityl
Oxide and Pulegone. Pol. J . Chem. 1978, 52, 1389-1394.
(23) Hunziker, F.; Fischer, R.; Kipfer, P.; Schmutz, J .; Bu¨rki, H. R.;
Eichenberg, E.; White, T. G. Neuroleptic Piperazinyl Derivatives
of 10H-Thieno[3,2-c][1]benzazepines and 4H-Thieno[2,3-c][1]-
benzazepines. Eur. J . Med. Chem. 1981, 16, 391-398.
(24) Camps, P.; Morral, J .; Mun˜oz-Torrero, D. On the Synthesis of
2-Amino-4,6-difluorobenzonitrile: Highly Selective Formation of
5-Fluoro-3-nitro-1,2-benzoquinone 2-Diazide in the Attempted
Sandmeyer Cyanation of 2,4-Difluoro-6-nitrobenzenediazonium
Cation. J . Chem. Res. (S) 1998, 144-145.
(43) Bayly, C. I.; Cieplak, P.; Cornell, W. D.; Kollman, P. A. A Well-
Behaved Electrostatic Potential Based Method Using Charge
Restraints for Deriving Atomic Charges. J . Chem. Phys. 1993,
97, 10269-10280.
(44) J orgensen, W. L. BOSS, version 3.4; Yale University: New
Haven, CT, 1990.
(45) Ryckaert, J . P.; Ciccotti, G.; Berendsen, H. J . C. Numerical
Integration of the Cartesian Equations of Motion of a System
with Constraints: Molecular Dynamics of n-Alkanes. J . Comput.
Phys. 1977, 23, 327-341.
(46) Case, D. A.; Pearlman, D. A.; Caldwell, J . C.; Cheatham, T. E.;
Ross, W. S.; Simmerling, C.; Darden, T.; Merz, K. M.; Stanton,
R. V.; Cheng, A.; Vincent, J . J .; Crowley, M.; Ferguson, D. M.;
Radmer, R.; Seibel, G. L.; Singh, U. C.; Weiner, P.; Kollman, P.
A. AMBER5; University of California: San Francisco, CA, 1997.
(25) Grivsky, E. M.; Hitchings, G. H. Synthesis of 2-Chloro-4-
acetylaminobenzonitrile Isomeres. Structurally Related Com-
pounds with Biological Activities. Ind. Chim. Belge 1974, 39,
490-500.
(26) Bogert, M. T.; Hoffman, A. Some Acyl Derivatives of Bromoan-
thranilic Nitrile, and the 7-Methyl-4-ketodihydroquinazolines
Prepared Therefrom. J . Am. Chem. Soc. 1905, 27, 1293-1301.
J M000980Y